National Health Investors (NHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

26.02.25 01:00 Uhr

Werte in diesem Artikel

National Health Investors (NHI) reported $85.75 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 7.9%. EPS of $1.13 for the same period compares to $0.74 a year ago.The reported revenue represents a surprise of +2.52% over the Zacks Consensus Estimate of $83.64 million. With the consensus EPS estimate being $1.10, the EPS surprise was +2.73%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how National Health Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Rental income: $65.78 million versus the two-analyst average estimate of $62.06 million. The reported number represents a year-over-year change of +8.3%. Revenues- Interest income and other: $5.97 million versus $5.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3% change. Revenues- Resident fees and services: $14 million versus the two-analyst average estimate of $13.88 million. The reported number represents a year-over-year change of +8.1%. Earnings per common share- Diluted: $0.95 versus $0.71 estimated by three analysts on average. View all Key Company Metrics for National Health Investors here>>>Shares of National Health Investors have returned -0.2% over the past month versus the Zacks S&P 500 composite's -1.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report National Health Investors, Inc. (NHI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf National Health Investors

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf National Health Investors

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu National Health Investors IncShs

Wer­bung

Analysen zu National Health Investors IncShs

DatumRatingAnalyst
22.02.2019National Health Investors UnderperformBMO Capital Markets
09.11.2015National Health Investors BuyStifel, Nicolaus & Co., Inc.
08.05.2015National Health Investors NeutralMizuho
10.04.2015National Health Investors OutperformBMO Capital Markets
03.03.2015National Health Investors NeutralMizuho
DatumRatingAnalyst
09.11.2015National Health Investors BuyStifel, Nicolaus & Co., Inc.
10.04.2015National Health Investors OutperformBMO Capital Markets
DatumRatingAnalyst
08.05.2015National Health Investors NeutralMizuho
03.03.2015National Health Investors NeutralMizuho
DatumRatingAnalyst
22.02.2019National Health Investors UnderperformBMO Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für National Health Investors IncShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"